94 related articles for article (PubMed ID: 19606194)
1. Effect of demographic variables on cytomegalovirus antibody seropositivity among prospective blood donors in Jos, Nigeria.
Alao OO; Mamman A; Araoye MO; Joseph E
Niger Postgrad Med J; 2009 Jun; 16(2):139-42. PubMed ID: 19606194
[TBL] [Abstract][Full Text] [Related]
2. Effect of Demographic Variables on Cytomegalovirus Antibody Seropositivity among Prospective Blood Donors in Jos, Nigeria.
Oginni FO; Alao OO; Mamman A; Araoye MO; Joseph E
Niger Postgrad Med J; 2009 Mar; 16(1):21-4. PubMed ID: 19305433
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of cytomegalovirus among voluntary blood donors in Delhi, India.
Kothari A; Ramachandran VG; Gupta P; Singh B; Talwar V
J Health Popul Nutr; 2002 Dec; 20(4):348-51. PubMed ID: 12659416
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of cytomegalovirus antibody in Thai-northeastern blood donors.
Urwijitaroon Y; Teawpatanataworn S; Kitjareontarm A
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():180-2. PubMed ID: 7886568
[TBL] [Abstract][Full Text] [Related]
5. [Is serologic screening necessary in the donor bloods for cytomegalovirus seronegative blood transfusion to risky patients?].
Mutlu B; Günlemez A; Türker G; Gökalp AS; Willke A
Mikrobiyol Bul; 2008 Apr; 42(2):337-41. PubMed ID: 18697432
[TBL] [Abstract][Full Text] [Related]
6. Is screening for IgG antibody to cytomegalovirus and Epstein-Barr virus infections mandatory in potential renal transplant recipients and donors in Iran?
Saghafi H; Qorashi M; Heidari A
Transplant Proc; 2009 Sep; 41(7):2761-3. PubMed ID: 19765428
[TBL] [Abstract][Full Text] [Related]
7. PREVALENCE AND ASSOCIATED CHARACTERISTICS OF CYTOMEGALOVIRUS (CMV) IMMUNOGLOBULIN ANTIBODIES AMONG BLOOD DONORS AT A UNIVERSITY TEACHING HOSPITAL IN NIGERIA.
Bolarinwa RA; Donbraye E; Ademosu AA; Salawu L
East Afr Med J; 2014 Nov; 91(11):385-90. PubMed ID: 26866086
[TBL] [Abstract][Full Text] [Related]
8. The seroprevalence of cytomegalovirus antibodies among prospective blood donors in Jos.
Alao OO; Joseph DE; Mamman A; Banwat EB
Niger J Med; 2008; 17(2):198-200. PubMed ID: 18686839
[TBL] [Abstract][Full Text] [Related]
9. High seropositivity of IgG and IgM antibodies against cytomegalovirus (CMV) among HIV-1 seropositive patients in Ilorin, Nigeria.
Fowotade A; Okonko IO; Agbede OO; Suleiman ST
Afr Health Sci; 2015 Mar; 15(1):1-9. PubMed ID: 25834524
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus seroprevalence among solid organ donors in Hungary: correlations with age, gender, and blood group.
Varga M; Görög D; Kári D; Környei E; Kis É; Túryné HJ; Jankovics I; Péter A; Toronyi É; Sárváry E; Fazakas J; Reusz G
Transplant Proc; 2011 May; 43(4):1233-5. PubMed ID: 21620098
[TBL] [Abstract][Full Text] [Related]
11. [Significance of cytomegalovirus in blood donation].
Albert S; Kühnl P; Sibrowski W; Seidl S; Doerr HW
Infusionstherapie; 1990 Feb; 17(1):48-56. PubMed ID: 2159951
[TBL] [Abstract][Full Text] [Related]
12. [Investigation of cytomegalovirus seroepidemiology in Antalya with a population-based cross-sectional study and review of related data in Turkey].
Ataman S; Colak D; Günseren F; Senol Y; Colak T; Aktekin MR; Gültekin M
Mikrobiyol Bul; 2007 Oct; 41(4):545-55. PubMed ID: 18173073
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus antibody status and kidney transplantation.
Terasaki PI; Yuge J; Cecka JM; Gjertson DW
Clin Transpl; 1994; ():509-18. PubMed ID: 7547579
[TBL] [Abstract][Full Text] [Related]
14. Blood donor safety, prevalence and associated factors for cytomegalovirus infection among blood donors in Minna-Nigeria, 2014.
Bawa MK; Mamman A; Olayinka A; Gidado S; Waziri NE; Balogun MS; Getso KI; Dalhat MM; Nsubuga P; Aliyu N; Bala H; Muhammad H; Haladu S; Shehu UL; Nguku PM
Pan Afr Med J; 2019; 32(Suppl 1):6. PubMed ID: 30984327
[TBL] [Abstract][Full Text] [Related]
15. Recognition of cytomegalovirus clinical isolate antigens by sera from cytomegalovirus-negative blood donors.
Rahbar AR; Sundqvist VA; Wirgart BZ; Grillner L; Söderberg-Naucler C
Transfusion; 2004 Jul; 44(7):1059-66. PubMed ID: 15225248
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of cytomegalovirus antibodies in blood donors at the National Blood Transfusion Centre, Nairobi.
Njeru DG; Mwanda WO; Kitonyi GW; Njagi EC
East Afr Med J; 2009 Dec; 86(12 Suppl):S58-61. PubMed ID: 21591511
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of cytomegalovirus in Thai blood donors by monoclonal staining of blood leukocytes.
Amarapal P; Tantivanich S; Balachandra K
Southeast Asian J Trop Med Public Health; 2001 Mar; 32(1):148-53. PubMed ID: 11485078
[TBL] [Abstract][Full Text] [Related]
18. Seroepidemiologic study of herpes simplex virus type 2 and cytomegalovirus among young adults in northern Jordan.
Abuharfeil N; Meqdam MM
New Microbiol; 2000 Jul; 23(3):235-9. PubMed ID: 10939038
[TBL] [Abstract][Full Text] [Related]
19. The risk of transfusion-acquired hepatitis-C virus infection among blood donors in Port Harcourt: the question of blood safety in Nigeria.
Erhabor O; Ejele OA; Nwauche CA
Niger J Clin Pract; 2006 Jun; 9(1):18-21. PubMed ID: 16986284
[TBL] [Abstract][Full Text] [Related]
20. Persistent infections and their relationship with selected oncologic and non-tumor pathologies.
Chumak AA; Abramenko IV; Bilous NI; Filonenko IA; Kostin OV; Pleskach OY; Pleskach GV; Efremova N; Yanko J
J Immunotoxicol; 2010; 7(4):279-88. PubMed ID: 20518708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
